Status:
ACTIVE_NOT_RECRUITING
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
Andy Hill Cancer Research Endowment (CARE) Fund
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates a clinical trial navigation intervention to help increase participation and diversity in cancer clinical trials. Cancer clinical trials are an important part of the devel...
Detailed Description
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients meet with a clinical trial navigator to understand activities involved with clinical trials, identify financial barriers to clinical t...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years of age
- Identified as potentially eligible for an open clinical trial by clinical trial pre-screening
- Have ≥ 1 health related social need, defined by
- Food insecurity, housing instability, transportation challenges, or financial instability documented in the Supportive Cancer Care Questionnaire in Epic Electronic Medical Record (EPIC), OR
- Concerns about insurance, cost of trial, additional trial visits, travel, transportation, childcare/eldercare, OR unable to take time off work, etc., as documented by clinical trial pre-screening (CTPS) or provider, OR
- Medicaid insurance (including Medicaid pending) documented in EPIC, OR
- Respond affirmatively (yes, maybe, possibly, I think so, etc.) to the social needs screening question asked by our Research Coordinator: "During your cancer treatment, are you interested in assistance with transportation, food, housing, financial resources, or other barriers to treatment?"
- Able to speak English
Exclusion
- Unable to speak English
- Children, adolescents, and teens under the age of 18 years
- Patients participating on clinical trials providing financial navigation, such as clinicaltrials.gov identifier (CT ID): NCT04960787
- Patients refusing to sign Health Insurance Portability and Accountability Act (HIPAA) authorization
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06484595
Start Date
September 23 2024
End Date
March 31 2026
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109